Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06371950

Gut Microbiome in Orthopaedics

Gut Microbiome in Orthopaedics: Effect of Probiotics on Initial Implant Migration and Joint Inflammation After Total Knee Replacement

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
Female
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients having knee replacement surgery regularly experience joint pain and compromised bone quality leading to implant loosening and periprosthetic fractures. The role of the gut microbiome, which is the collection of bacteria and other microbes within the human gastrointestinal tract, is just beginning to be recognized, including its potential effects on pain, infection, and loosening after total joint replacement. Antibiotics are regularly used in orthopaedic surgery to reduce the risk of infection, but they also harm gut microbiota and reduce their potentially beneficial effects. Probiotics may have a role to play in enhancing bone quality and decreasing synovial inflammation after joint replacement surgery, and this study will explore the potential relationship of probiotic use with implant migration, bone density, and patient outcomes. This study is a randomized, controlled, double-blinded trial comparing probiotic use with placebo in post-menopausal women undergoing primary total knee replacement. The main questions it aims to answer are: * to compare implant migration between groups from baseline to six weeks post-surgery * to compare bone density and joint inflammation between groups from baseline to six weeks post-surgery * to compare gut microbiome composition and patient-reported outcome measures between groups from baseline to six weeks post-surgery

Detailed description

Participants will take a daily probiotic (DE111®) or placebo once daily starting 3 weeks prior to surgery until six weeks after surgery. The following will be completed at baseline and 6 weeks: * Bloodwork * Fecal sample collection * MRSA swab * Patient-reported outcome measures * CT imaging scan In addition, the following will be done: * Intraoperative fluid and tissue collection * Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI) scan at 6 weeks post-surgery Researchers will compare the probiotic and placebo groups for any significant differences in implant stability, bone quality, inflammation, gut microbiome composition, and pain.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic Formula Bacillus subtilis5 billion colony forming units (CFU) per day for 9 weeks (3 weeks before surgery to six weeks after surgery)
OTHERPlaceboPlacebo

Timeline

Start date
2025-01-01
Primary completion
2027-01-01
Completion
2028-01-01
First posted
2024-04-17
Last updated
2025-03-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06371950. Inclusion in this directory is not an endorsement.